In April 1928, Dr. Roe E. Remington, of the faculty of the University of Minnesota, was in Charleston on a tour of the state under the auspices of the recently
stock.adobe.com
A new drug that could help more than 128 million Americans read without needing glasses has been submitted to the federal Food and Drug Administration for approval.
The eye drop called AGN-190584 is expected to be approved by the end of this year, according to Allergan Eye Care, which is owned by AbbVie.
The eye drops are a pilocarpine solution meant to treat the symptoms of presbyopia, an age-related condition that causes gradual loss of the eyes’ ability to focus on nearby objects.
It’s a natural but annoying part of aging, said Dr. Robert S. Bailey, chief of the Cataract and Primary Eye Care Service at Wills Eye Hospital in Philadelphia.
A new drug that could help more than 128 million Americans read without needing glasses has been submitted to the Food and Drug Administration for approval.
The eye drops are a pilocarpine solution meant to treat the symptoms of presbyopia, an age-related condition that causes gradual loss of the eyes’ ability to focus on nearby objects, according to the Mayo Clinic.
It’s a natural but annoying part of aging, said Dr. Robert S. Bailey, chief of the Cataract and Primary Eye Care Service at Wills Eye Hospital in Philadelphia.
“It happens from (the age) of 10 and then you gradually lose that focusing ability to the age of 70 when you lose the ability totally,” he said. Most patients begin to notice it in their mid-40s.
Tired of reading glasses? Eye drop submitted for FDA approval may help you read without them msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.